Small Molecule
O4S
14808-79-8
The sulfate ion (DrugBank ID: DB14546, CAS: 14808-79-8), a simple divalent anion, represents a molecule of profound and multifaceted significance. While it possesses direct pharmacological activity as a medication, specifically as an osmotic laxative, this application constitutes only a narrow facet of its overall importance. This report provides a comprehensive, multi-domain analysis of the sulfate ion, revealing its identity as a fundamental biological component, a critical tool in pharmaceutical sciences, a versatile industrial chemical, and a major environmental agent. Biologically, sulfate is the fourth most abundant anion in human plasma, essential for detoxification, metabolic regulation, and the structural integrity of tissues. Its role in the sulfonation of hormones, neurotransmitters, and xenobiotics is a cornerstone of human physiology, and its availability is critical for proper fetal development. In pharmacology, beyond its use as a laxative, sulfate's primary contribution is as a counter-ion. By forming salts with basic active pharmaceutical ingredients (APIs), it enhances their solubility, stability, and bioavailability, making many essential drugs—from antibiotics to opioids—viable for clinical use. Industrially, sulfate compounds are cornerstones of agriculture, construction, and manufacturing. Environmentally, sulfate presents a complex paradox: it is the principal agent of acid rain, causing widespread ecological damage, yet as an atmospheric aerosol, it exerts a significant cooling effect on the global climate. This report synthesizes these disparate roles, demonstrating that the function and impact of the sulfate ion are entirely defined by its chemical, biological, and environmental context. Understanding this context is essential for clinicians, scientists, and policymakers alike.
The foundation for understanding the diverse roles of the sulfate ion lies in its fundamental chemical and physical properties. Its structure, charge, and interactions with other molecules dictate its behavior in biological systems, pharmaceutical formulations, and the environment.
The sulfate ion is a ubiquitous chemical entity tracked across numerous international scientific and regulatory databases, a testament to its broad relevance. Its primary identifiers are the Chemical Abstracts Service (CAS) number [14808-79-8] and the DrugBank Accession Number [DB14546].[1] It is known by several synonyms, including sulfate, sulphate, sulfate dianion, sulfate(2-), and sulfuric acid ion(2-).[1] Its formal IUPAC name is simply
[sulfate].[2]
The extensive list of identifiers underscores its importance in various domains:
The presence of identifiers from agencies governing pharmaceuticals (DrugBank, FDA), environmental protection (EPA), chemical safety (ECHA), and cancer research (NCI) immediately signals that the sulfate ion is far more than a simple medication; it is a fundamental molecule with impacts across health, industry, and the environment.
The chemical nature of the sulfate ion explains its stability and reactivity. Its molecular formula is SO42−.[2] It is a polyatomic anion with an average molecular weight of approximately 96.06 g/mol.[1]
Structurally, the ion exhibits a [tetrahedral geometry], with a central sulfur atom covalently bonded to four equivalent oxygen atoms.[7] The angle between the oxygen atoms is the ideal tetrahedral angle of 109.5 degrees, and the sulfur-oxygen bond length is 149 picometers (pm).[5] Within this structure, the central sulfur atom exists in the
[+6 oxidation state], while each of the four oxygen atoms is in the [-2 state], resulting in the overall divalent negative charge (2−).[8]
The nature of the S-O bond has been a subject of evolving scientific understanding. While early models by Lewis and Pauling described resonance structures involving double bonds and d-orbital participation, modern computational analyses provide a more nuanced picture. These studies confirm a significant degree of [ionic character] in the S-O bonds and a clear positive charge on the sulfur atom (theoretically +2.45).[9] This substantial charge separation is a key feature, making the sulfate ion highly polar and capable of forming strong electrostatic interactions with cations. This property is fundamental to its role in forming stable salts with basic drug molecules and its specific interactions with positively charged amino acid residues in proteins.
Chemically, the sulfate ion is a sulfur oxoanion and is the conjugate base of the hydrogensulfate (or bisulfate) ion (HSO4−), which, in turn, is the conjugate base of sulfuric acid (H2SO4).[2]
In practice, the sulfate ion is encountered as part of an ionic compound, or salt. These sulfate salts are typically white or colorless crystalline solids.[7] A defining characteristic of most ionic sulfates is their
[high solubility in water].[6] This property is crucial for their biological availability and widespread use in aqueous solutions for industrial and pharmaceutical purposes.
However, there are several notable exceptions to this rule. The sulfates of certain alkaline earth and heavy metals are poorly soluble or effectively insoluble. These include:
This poor solubility is not a limitation but a property that is exploited in various applications. For example, the insolubility of barium sulfate allows it to be used safely as a radiocontrast agent for gastrointestinal imaging, as it passes through the body without being absorbed.[10] The precipitation of barium sulfate upon adding a barium salt solution to a sample is also a classic and reliable laboratory test for the qualitative and quantitative (gravimetric) analysis of sulfate ions.[6]
[Table 1: Key Identifiers and Physicochemical Properties of the Sulfate Ion]
| Property | Value | Source(s) |
|---|---|---|
| DrugBank ID | DB14546 | 1 |
| CAS Number | 14808-79-8 | 2 |
| Molecular Formula | SO42− | 2 |
| Average Weight | 96.063 g/mol | 1 |
| IUPAC Name | Sulfate | 2 |
| Structure | Tetrahedral | 8 |
| S Oxidation State | +6 | 8 |
| O Oxidation State | -2 | 8 |
| Chemical Nature | Divalent inorganic anion; conjugate base of HSO4− | 2 |
| General Solubility | Most sulfate salts are highly soluble in water | 6 |
| Key Insoluble Salts | BaSO4, PbSO4, SrSO4, CaSO4 | 6 |
Far from being a foreign substance, the sulfate ion is an integral and indispensable component of human physiology. It is not merely an inert ion but an active participant in a vast array of metabolic and structural processes that are essential for health, development, and detoxification.
Sulfate is a critical macronutrient required by all cells for normal function and is the [fourth most abundant anion in human plasma], with typical concentrations around 300 μM.[11] The body's supply of sulfate is maintained through two primary sources: direct intake from the diet and endogenous production from the metabolic breakdown of sulfur-containing amino acids, principally
[methionine and cysteine].[2]
The maintenance of stable circulating sulfate levels, or homeostasis, is a vital physiological process managed predominantly by the [kidneys]. The kidneys filter sulfate from the blood at the glomerulus and then precisely regulate how much is reabsorbed back into circulation versus excreted in the urine. This reabsorption is an active process mediated by specialized [sulfate transporter proteins] located on the membranes of renal epithelial cells. Key transporters identified include NaSi-1 (coded by the gene SLC13A1) and sat-1 (SLC26A1), which work in concert to retain this essential anion in the body.[12] This tight renal control underscores the biological importance of maintaining an adequate sulfate supply for cellular processes.
One of the most critical roles of sulfate is its participation in the [sulfonation pathway], a major Phase II metabolic reaction. This process, which occurs in the cytosol of cells, is essential for both detoxification and the regulation of endogenous molecules.[11] The reaction is catalyzed by a family of enzymes known as
[sulfotransferases (SULTs)]. These enzymes transfer a sulfonate group (SO3−) from a universal donor molecule to a substrate.[11] This addition makes the substrate more polar and water-soluble, which facilitates its excretion from the body, thereby detoxifying potentially harmful xenobiotics like drugs and environmental toxins.[11]
The sulfonate group is not transferred from free sulfate directly. Instead, the cell must first "activate" the sulfate by converting it into [3'-phosphoadenosine-5'-phosphosulfate (PAPS)]. This high-energy molecule serves as the universal sulfonate donor for all SULT-catalyzed reactions.[13] The synthesis of PAPS is an energy-dependent process, highlighting the metabolic investment the body makes to ensure sulfonation can proceed efficiently.
The sulfonation pathway is not limited to detoxification; it is a fundamental mechanism for regulating the activity of numerous biologically important molecules and for building essential structural components of the body.
Sulfonation acts as a dynamic molecular "switch" that modulates the function of many endogenous compounds. The body uses this process to reversibly activate or inactivate key molecules, with the ratio of sulfated to unsulfated forms serving as a critical physiological control mechanism.[13] Key examples include:
Sulfate is a fundamental building block for a class of complex carbohydrates known as [glycosaminoglycans (GAGs)]. These include molecules like [heparan sulfate], [chondroitin sulfate], and [dermatan sulfate].[11] GAGs are typically attached to core proteins to form even larger molecules called
[proteoglycans]. These sulfated proteoglycans are major components of the extracellular matrix, the scaffold that surrounds cells. They are absolutely essential for the structural integrity, hydration, and mechanical properties of connective tissues, particularly [cartilage and bone].[11]
The requirement for sulfate is never more critical than during fetal development. The fetus has a limited capacity to generate its own sulfate and is therefore almost entirely dependent on a continuous supply from the mother, transported across the placenta.[13] To meet the immense demands of the growing fetus for building its skeleton and other tissues, maternal blood sulfate concentrations naturally double from mid-gestation onwards. This establishes a critical physiological axis: maternal diet and kidney function dictate circulating sulfate levels, which in turn determine placental transport and fetal availability. Disruptions in this supply chain, leading to maternal hyposulfataemia (low blood sulfate), have been linked in animal models to fetal loss and in humans to a range of developmental disorders, most notably
[skeletal dysplasias] (disorders of bone and cartilage growth).[11]
While sulfate's biological roles are vast, it also has a distinct identity as a "medication," where the ion itself is the active pharmaceutical ingredient (API). This use, however, is confined to a specific therapeutic class and relies on a physical mechanism rather than a classical biochemical one.
The U.S. Food and Drug Administration (FDA) and other regulatory bodies classify the sulfate ion, when used as an API, under the established pharmacologic class of [Osmotic Laxative].[2] This classification applies to orally administered salts of sulfate, such as sodium sulfate, potassium sulfate, and magnesium sulfate, which are formulated as hypertonic solutions for bowel cleansing.
The mechanism of action (MoA) of sulfate as a laxative is based on its physical property of [osmotic activity] within the gastrointestinal (GI) tract.[2] Unlike most nutrients and drugs, sulfate ions are poorly absorbed from the GI lumen into the bloodstream. When a concentrated solution of sulfate salts is ingested, a high concentration of these non-absorbable ions is established within the colon.
This high solute concentration creates a strong osmotic gradient that profoundly alters fluid balance in the large intestine, leading to two primary physiological effects:
The combined result is a rapid and thorough evacuation of the bowel, a cathartic effect that is utilized clinically for cleansing the colon prior to diagnostic procedures like colonoscopy or radiological examinations.[2]
Beyond its physical osmotic mechanism, the sulfate ion has a documented interaction with a specific molecular target: [Carbonic Anhydrase 1] (UniProt ID: P00915).[4] This presents a fascinating duality in its pharmacological profile.
Carbonic anhydrases are a family of zinc-containing metalloenzymes that catalyze the rapid interconversion of carbon dioxide and water to bicarbonate and protons. They are vital for pH regulation, CO₂ transport, and fluid secretion in various tissues. As a small anion, the sulfate ion can act as an inhibitor of this enzyme, likely by binding to the positively charged zinc ion in the enzyme's active site and displacing the water molecule required for catalysis.
The clinical significance of this enzymatic interaction in the context of its use as an oral laxative is likely negligible. Because the sulfate ion is poorly absorbed, the systemic concentrations achieved are too low to cause meaningful inhibition of carbonic anhydrase throughout the body. However, the existence of this specific biochemical interaction is scientifically important. It demonstrates that the sulfate ion is not merely an osmotically active but biochemically inert substance. This interaction could potentially be relevant in specific physiological or pathological conditions where local sulfate concentrations become abnormally high, or it could inform the design of novel, sulfate-mimicking carbonic anhydrase inhibitors for other therapeutic purposes. This duality—a primary therapeutic effect driven by a non-specific physical property (osmosis) and a secondary, specific biochemical interaction at a molecular target—highlights the chemical versatility of this simple ion.
The classification of the sulfate ion as an "Investigational" drug by DrugBank reflects its ongoing use in clinical research.[1] However, a critical analysis of the clinical trial data reveals that its role is highly context-dependent. The simple presence of "Sulfate ion (DB14546)" in a trial's list of interventions can be misleading, as its function ranges from being the primary active agent to an inert formulation component. Dissecting this context is crucial to accurately understanding its clinical development landscape.
The sulfate ion is listed as an investigational small molecule, primarily due to its inclusion in various clinical studies that are either ongoing or have been recently completed.[1] These trials span a wide range of therapeutic areas, including gastroenterology, anesthesiology, and oncology.
A systematic review of specific trials illustrates the varied roles of the sulfate ion.
In trial [NCT05923918], a recruiting Phase 3 study, a product named PBK_M2101 is being evaluated for diagnostic purposes in patients with digestive system, colonic, and intestinal diseases.[20] In this context, the sulfate ion is the principal active ingredient of an oral solution designed for bowel cleansing. Its function is directly tied to its established mechanism as an osmotic laxative, intended to prepare the colon for effective visualization during diagnostic procedures. This is the most straightforward example of sulfate being investigated as the primary API.
Trial [NCT02920905] was a completed Phase 3 study that examined the use of Atracurium mixed with [Magnesium Sulfate] as an adjuvant to Lidocaine in intravenous regional anesthesia (IVRA) for managing post-operative pain.[21] Here, the sulfate ion is part of the compound magnesium sulfate. While the sulfate ion is listed (DB14546), the therapeutic effect is attributed to the magnesium ion, which possesses analgesic and muscle-relaxant properties that can potentiate the anesthetic, and potentially to synergistic effects of the entire salt. The sulfate ion is not acting alone but as part of a therapeutically active salt.
Many clinical trials list the sulfate ion simply because it is the stoichiometric counter-ion for a different active drug being studied. This is a common source of misinterpretation if not analyzed carefully.
This analysis reveals a critical lesson in interpreting clinical trial databases: the simple association of a molecule like the sulfate ion with a trial for a specific disease does not imply it has a therapeutic effect for that disease. It is essential to investigate the full context, including the other drugs administered and their formulations, to determine whether the ion is the intended API, part of an adjuvant, or merely an inert but necessary component of another drug's formulation.
[Table 2: Summary of Key Clinical Trials Involving Sulfate Ion (DB14546)]
| NCT Identifier | Phase & Status | Indication | Other Key Drugs | Interpreted Role of Sulfate Ion | Source(s) |
|---|---|---|---|---|---|
| NCT05923918 | Phase 3, Recruiting | Gastrointestinal Disorder (Diagnostic) | PBK_M2101 | Active API (Osmotic Laxative for Bowel Cleansing) | 20 |
| NCT02920905 | Phase 3, Completed | Post-Operative Pain | Lidocaine, Atracurium, Magnesium Sulfate | Adjuvant Component (as part of Magnesium Sulfate) | 21 |
| NCT02541565 | Phase 1, Completed | Grade 3b Follicular Lymphoma | Pembrolizumab, Rituximab, Vincristine, etc. | Inert Counter-Ion (for Vincristine Sulfate) | 22 |
| NCT00080847 | Phase 2, Terminated | Diffuse Large Cell Lymphoma | Rituximab, Vincristine, etc. | Inert Counter-Ion (for Vincristine Sulfate) | 23 |
| NCT04565678 | Phase 1, Completed | Healthy Volunteers | Mitapivat | Inert Counter-Ion (for Mitapivat Sulfate) | 24 |
While the sulfate ion's role as an active drug is limited, its contribution to medicine is immense and primarily lies in its function as a tool in pharmaceutical formulation. It is one of the "unsung heroes" of drug development, an enabling technology that allows hundreds of active pharmaceutical ingredients (APIs) to be formulated into safe, stable, and effective medicines.
More than half of all small-molecule drugs on the market are administered as salts.[25] The formation of a salt is a deliberate and critical strategy used by pharmaceutical scientists to overcome undesirable properties of an API in its "free" or non-ionized form. Many APIs, particularly those that are basic (containing amine groups), have poor water solubility, low stability, or unpredictable dissolution rates. By reacting the basic API with an acid, a salt is formed, which is an ionic compound composed of the protonated (cationic) API and the acid's conjugate base (the anion, or counter-ion).
Sulfate is a frequently chosen counter-ion for this purpose, accounting for 5-10% of all pharmaceutical salts, second in prevalence only to chloride.[26] Its key advantages include:
The accurate measurement of the sulfate concentration in a final drug product is a critical quality control step. It is used to confirm the correct molecular weight of the salt, verify the stoichiometric ratio between the drug and the counter-ion, and ensure the completeness of the salt formation reaction.[26]
The importance of the sulfate counter-ion is best illustrated by the vast range of essential medicines that depend on it for their clinical utility.
[Table 3: Representative Pharmaceutical Agents Formulated as Sulfate Salts]
| Drug Name (Sulfate Salt) | Therapeutic Class | Rationale for Sulfate Salt Formulation | Source(s) |
|---|---|---|---|
| Morphine Sulfate | Opioid Analgesic | Improves water solubility for injection and allows for controlled-release oral formulations. | 28 |
| Salbutamol Sulfate | Beta-2 Agonist (Bronchodilator) | Provides a stable, water-soluble form suitable for use in metered-dose inhalers and nebulizer solutions. | 29 |
| Paromomycin Sulfate | Aminoglycoside Antibiotic | Sulfate is the most common counter-ion for this class, providing a stable, solid form for oral capsules. | 26 |
| Vincristine Sulfate | Vinca Alkaloid (Antineoplastic) | Creates a stable, lyophilized powder for reconstitution into an injectable solution for chemotherapy. | 22 |
| Atropine Sulfate | Anticholinergic Agent | Enhances solubility for parenteral administration in emergency medicine. | 1 |
| Iron(II) Sulfate | Nutritional Supplement | Provides a bioavailable source of iron for treating and preventing iron-deficiency anemia. | 9 |
| Zinc Sulfate | Nutritional Supplement | Used to treat and prevent zinc deficiency. | 10 |
| Magnesium Sulfate | Anticonvulsant / Electrolyte | Highly water-soluble salt used intravenously to treat eclampsia and hypomagnesemia. | 6 |
| Chondroitin Sulfate | Dietary Supplement | A sulfated GAG used for osteoarthritis, though it is a covalently bonded sulfate, not an ionic salt. | 18 |
In addition to being a counter-ion for APIs, sulfate-containing compounds are also used as inactive ingredients, or excipients, in drug formulations.
The safety profile of the sulfate ion is complex and highly dependent on its context: its cationic partner, the route of administration, the dose, and the species being treated. While the ion itself is relatively benign, its salts can have significant toxicity, and its use as a laxative is associated with a number of clinically relevant drug interactions.
When used as an osmotic laxative, the sulfate ion's efficacy and safety can be altered by concomitant medications. These interactions are primarily pharmacodynamic, relating to opposing or additive effects on gastrointestinal function and fluid balance.
[Table 4: Summary of Clinically Significant Drug Interactions with Sulfate Laxatives]
| Interacting Drug/Class | Mechanism of Interaction | Clinical Consequence | Representative Drugs | Source(s) |
|---|---|---|---|---|
| Anticholinergic Agents | Decrease GI motility, opposing the pro-motility effect of the osmotic laxative. | Decreased Therapeutic Efficacy of the sulfate laxative. | Atropine, Aclidinium, Benzatropine, Biperiden | 1 |
| Opioid Analgesics | Cause constipation by slowing GI transit time. | Decreased Therapeutic Efficacy of the sulfate laxative. | Alfentanil, Codeine, Dihydrocodeine, Morphine, Benzhydrocodone | 1 |
| Antipsychotics / Antidepressants | Many have significant anticholinergic side effects. | Decreased Therapeutic Efficacy of the sulfate laxative. | Amitriptyline, Amoxapine, Clozapine, Chlorpromazine | 1 |
| Stimulant Laxatives | Additive laxative effects. | Increased Risk of Adverse Effects (e.g., dehydration, electrolyte imbalance, abdominal cramping). | Alloin, Bisacodyl, Bisoxatin | 1 |
| Diuretics | Promote renal excretion of water and electrolytes. | Increased Risk of Dehydration and electrolyte disturbances. | Acetazolamide, Amiloride, Benzthiazide, Bendroflumethiazide | 1 |
| Aluminum-Containing Antacids | May bind to sulfate or otherwise interfere with its osmotic action. | Decreased Therapeutic Efficacy of the sulfate laxative. | Aluminum hydroxide, Aluminium phosphate, Almasilate | 1 |
It is crucial to distinguish between the toxicity of the sulfate ion itself and the toxicity of its various salts, as the latter is almost entirely dictated by the cationic partner.
The sulfate ion is not considered a carcinogen. It is not listed as such by major regulatory and research bodies, including the U.S. Environmental Protection Agency (EPA), the National Toxicology Program (NTP), or the International Agency for Research on Cancer (IARC).[3] Animal studies on specific salts like zinc sulfate have produced inconclusive or conflicting results regarding carcinogenicity.[31] Similarly, while maternal sulfate
deficiency is known to be detrimental to development, studies on high-dose reproductive toxicity of specific sulfate salts have not established a clear risk.[31]
Beyond its roles in biology and medicine, the sulfate ion is a major commodity in the global economy and a key player in Earth's environmental systems. Its industrial applications are vast, and its atmospheric chemistry has profound consequences for ecosystems and the climate.
Sulfate compounds are integral to numerous industrial sectors due to their versatility and low cost.
The primary negative environmental impact of sulfate is its role as the main precursor to [acid rain]. This process begins with the combustion of fossil fuels (coal, oil) in power plants and industrial facilities, which releases large quantities of [sulfur dioxide (SO2)] gas into the atmosphere.[40]
Once in the atmosphere, the SO2 undergoes a series of chemical reactions, oxidizing and combining with water vapor to form [sulfuric acid (H2SO4)]. This acid exists in the form of microscopic liquid droplets or fine solid particles, known as sulfate aerosols.[6] These aerosols can be transported by winds for hundreds or even thousands of miles. Eventually, they are removed from the atmosphere through two processes:
The deposition of sulfuric acid has severe consequences for natural and man-made environments.
To fully appreciate the unique properties of the sulfate ion, it is instructive to compare it with its close chemical relatives: the sulfite ion (SO32−) and the thiosulfate ion (S2O32−). These three sulfur oxoanions, while structurally similar, exist at different oxidation states, which dictates their chemical reactivity, stability, and biological roles.
The key differences lie in their structure, the oxidation state of sulfur, and their resulting chemical stability.
These three ions are biochemically interlinked in the sulfur metabolic cycle.
This spectrum of reactivity, governed by the oxidation state of sulfur, dictates the distinct biological role of each ion: sulfate is the stable structural unit and final destination, sulfite is the reactive metabolic crossroads that must be tightly controlled, and thiosulfate is a specialized agent for specific redox tasks.
[Table 5: Comparative Properties of Sulfate, Sulfite, and Thiosulfate]
| Property | Sulfate | Sulfite | Thiosulfate |
|---|---|---|---|
| Chemical Formula | SO42− | SO32− | S2O32− |
| Sulfur Oxidation State(s) | +6 | +4 | Central: ~+5, Terminal: ~-1 |
| Key Chemical Property | Highly stable; poor redox agent | Reactive; mild reducing agent | Reactive; reducing agent |
| Primary Biological Role | Structural component (GAGs); detoxification end-product; nutrient | Reactive intermediate in amino acid metabolism | Intermediate; sulfur donor (e.g., for cyanide detoxification) |
| Toxicity / Safety Profile | Low toxicity; essential nutrient | Cytotoxic at high levels; can cause allergic reactions | Low toxicity; used as a drug (cyanide antidote) |
The comprehensive analysis of the sulfate ion reveals a molecule whose identity is not singular but is defined entirely by its context. It is a mistake to label it simply as a "medication," an "industrial chemical," or an "environmental pollutant," as it is all of these and more. Its true nature is that of a fundamental chemical entity whose function shifts dramatically depending on the system in which it operates.
This report has systematically deconstructed the multifaceted identity of the sulfate ion (DB14546).
Ultimately, the sulfate ion serves as a powerful example of how a simple molecule can have a complex and profound impact across every scale, from the active site of an enzyme to the global climate system. A holistic, context-aware perspective is the only way to truly understand its significance.
Despite its ubiquity, several areas warrant further investigation:
Based on the evidence synthesized in this report, the following recommendations can be made:
Published at: August 6, 2025
This report is continuously updated as new research emerges.
Empowering clinical research with data-driven insights and AI-powered tools.
© 2025 MedPath, Inc. All rights reserved.